Plaque Psoriasis

>

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.

Latest News

Deucravacitinib for Psoriasis Effective by Week 1, Sustained Over 52 Weeks
Deucravacitinib for Psoriasis Effective by Week 1, Sustained Over 52 Weeks

July 16th 2024

In this analysis, investigators highlighted the results of treating psoriasis with deucravacitinib in the phase 3 POETYK PSO-1 and PSO-2 trials.

Study Highlights Risk of PsA Among Psoriasis Patients with Type 2 Diabetes Mellitus
Study Highlights Risk of PsA Among Psoriasis Patients with Type 2 Diabetes Mellitus

July 15th 2024

Views on Use of Patient-Reported Outcome Measures for Itch Assessment
Views on Use of Patient-Reported Outcome Measures for Itch Assessment

July 15th 2024

Patients with Both Psoriasis, Hypertension Have Increased Mortality Likelihood
Patients with Both Psoriasis, Hypertension Have Increased Mortality Likelihood

July 15th 2024

Psoriasis, Psoriatic Arthritis Linked to Increased Polyneuropathy Risk
Psoriasis, Psoriatic Arthritis Linked to Increased Polyneuropathy Risk

July 13th 2024

Video Series
Video Interviews
Podcasts
MEDcast logo
Rebecca Kazin, MD
Valerie Callender, MD

More News

© 2024 MJH Life Sciences

All rights reserved.